Four insights:
1. Xiphos-ZF is the first implant developed from a new biomaterial called Zfuze.
2. Zfuze is a load-bearing biomaterial that evokes a pro-reparative macrophage phenotype rather than a pro-inflammatory phenotype.
3. Paul Kraemer, MD, of Indiana Spine Group in Carmel is set to perform the first spinal surgery with Xiphos-ZF.
4. DiFusion will launch Xiphos-ZF in the fourth quarter.
More articles on devices:
Orthofix reports $40.5M loss & more: 7 device company notes
Price transparency, value-based care & bundles: Altair Health CEO aims to drive change in spine
Stryker receives FDA clearance for 3D-printed expandable interbody device — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.